Assessment of Resistance Mechanisms and Clinical Implications in Patients With
                    <i>EGFR</i>
                    T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Public

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

Shared by NobleBlocks on Nov 1, 2018 • 12:00 AM UTC

Authors:

Geoffrey R. Oxnard

Yuebi Hu

Kathryn F. Mileham

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!